What Is Ketamine Therapy? The Performance-First Explainer

Ketamine therapy is the use of ketamine — a medication with fifty years of safety data in anesthesia — at sub-anesthetic doses to treat depression, anxiety, PTSD, and burnout-spectrum conditions, and increasingly to accelerate cognitive and emotional optimization in people who are not "sick" in any binary sense.

That last clause is where most explainers stop short. Mental health is not binary. It is a spectrum, and the same molecule can serve very different goals along it: pulling someone out of a treatment-resistant depressive episode is one goal. Giving a high performer a structured reset — a window of enhanced neuroplasticity in which to rebuild better patterns — is another. Both are legitimate. Only one gets talked about honestly.

How ketamine actually works

Most antidepressants work on serotonin and take four to six weeks to do anything measurable. Ketamine works on a completely different system: it blocks NMDA receptors, triggering a cascade that increases glutamate signaling and rapidly upregulates BDNF — brain-derived neurotrophic factor, the molecule most directly associated with synaptic growth.

In plain terms: ketamine opens a neuroplasticity window. For days to weeks after a session, the brain is measurably more capable of forming new connections and pruning old ones. Neuroplasticity is the most important word in mental performance, and ketamine is one of the few interventions that moves it acutely and reliably.

This is also why the session itself is only the beginning. A window that opens and closes with nothing built inside it is a wasted window. Integration — the structured therapeutic and behavioral work done while the window is open — is where the real work happens. Clinics that understand this design protocols around it. Clinics that do not are selling sessions.

The formats, compared honestly

- **IV infusion** — the most studied format, fully controllable dosing, typically six sessions over two to three weeks. The gold standard for clinical outcomes and the premium tier of the market. - **IM injection** — similar efficacy, faster onset, slightly less titratable. Common in psychiatrist-led practices. - **Intranasal (esketamine / Spravato)** — FDA-approved for treatment-resistant depression, administered in certified clinics, often insurance-eligible. The most medicalized path. - **Sublingual / oral** — lower bioavailability, often prescribed for at-home programs. The most accessible and the most variable in quality. Vet the provider hard.

None of these is universally "best." The right format depends on your goals, your screening profile, and — more than anything — the quality of the protocol wrapped around the molecule.

What it costs

Cash-pay is the norm in the premium tier. Expect roughly $400–$900 per IV session, with initial protocols of six sessions running $2,500–$5,500 depending on market and clinic tier. Esketamine is the main exception: with insurance approval, out-of-pocket costs can drop substantially, at the price of a more bureaucratic path.

Anyone quoting dramatically below market is cutting something. In this category, what gets cut is screening, monitoring, or integration — the three things that separate a clinic from a dispensary.

Who is a good candidate

Ketamine therapy screens in far more people than it screens out, but the screening is non-negotiable. Good candidates typically include people with depression or anxiety that has plateaued on conventional treatment, high performers carrying chronic stress load or burnout, and those seeking a structured reset with proper therapeutic support. Active psychosis, uncontrolled hypertension, and certain cardiovascular profiles are hard exclusions. Any clinic that does not run a real medical intake — history, vitals, contraindication review — before taking your money has told you everything you need to know about its standards.

The part nobody puts in the explainer: clinic quality variance

Here is the uncomfortable truth of this category: most clinics are mediocre. The gap between average and excellent is massive, and it is almost invisible from a Google listing. Two clinics can offer the same molecule at the same price and deliver outcomes that are not remotely comparable, because the molecule is the commodity. The protocol is the product.

What excellent looks like: physician-led intake, monitored sessions, defined integration work, measured baselines and outcomes. What mediocre looks like: a comfortable chair, a drip, and a follow-up email.

This is the entire reason NeuroEdge exists. We curate and vet clinics on exactly these dimensions, so the research you would have done over three weekends is already done.

The bottom line

Ketamine therapy is not a last resort and it is not a magic reset button. It is a powerful neuroplasticity intervention whose results are determined by what surrounds it — the screening before, the protocol during, and the integration after. Choose the clinic the way you would choose a surgeon, not the way you would choose a spa.

Ready to find out whether it fits your goals? Take the NeuroEdge matching assessment and we will point you at vetted clinics that meet the standard. Or keep reading The Brief — start with our deep dive on the neuroplasticity window and why integration is where the real work happens.